Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 15, Issue 12, 1996, Pages 913-921

  Falagas, M E ^a   Barefoot, L ^a   Griffith, J ^a   Ruthazar, R ^a   Snydman, D R ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTETAN; CEFOXITIN; SULTAMICILLIN;

ABDOMINAL INFECTION; ADULT; AGED; ARTICLE; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSEUDOMONAS; RISK FACTOR; SKIN INFECTION; SOFT TISSUE INFECTION; TREATMENT FAILURE;

ABDOMINAL ABSCESS; ADULT; AGE FACTORS; AGED; AMPICILLIN; ANTI-BACTERIAL AGENTS; CEFOTETAN; CEFOXITIN; CEPHAMYCINS; DRUG RESISTANCE, MICROBIAL; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PENICILLINS; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; SULBACTAM; TREATMENT OUTCOME;

EID: 0030471240     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01690508     Document Type: Article

References (29)

1. Bartlett JG: Intra-abdominal sepsis. Medical Clinics of North America 1995, 79: 599-617.
2. Swartz MN: Cellulitis and subcutaneous tissue infections. In: Mandell GL, Bennett JE, Dolin R (ed): Principles and practice of infectious diseases. Churchill Livingstone, New York, 1995, p. 909-928.
3. Condon RE, Wittmann DH: Approach to the patient with intra-abdominal infection. In: Gorbach SL, Bartlett JG, Blacklow NR (ed): Infectious diseases. Saunders, Philadelphia, 1992: 654-660.
4. Solomkin JS, Miyagawa CI: Principles of antibiotic therapy. Surgical Clinics of North America 1994, 74: 497-517.
5. Gorbach SL: Antibiotic treatment of anaerobic infections. Clinical Infectious Diseases 1994, 18, Supplement 4: 305.
6. Thadepalli H, Gorbach SL, Broido PW, Norsen J, Nyhus L: Abdominal trauma, anaerobes and antibiotics. Surgery, Gynecology and Obstetrics 1973, 137: 270.
7. Heseltine PNR, Yellin AE, Appleman MD, Gill MA, Chenella FC, Kern JW, Berne TV: Perforated and gangrenous appendicitis: an analysis of antibiotic failures. Journal of Infectious Diseases 1983, 148: 322-329.
8. Jaurequi LE, Applebaum PC, Fabian TC, Hageage G, Strausbaugh L, Martin LF: A randomized clinical study of cefoperazone and sulbactam versus gentamicin and clindamycin in the treatment of intra-abdominal infections. Journal of Antimicrobial Chemotherapy 1990, 25: 423-433.
9. Schentag JJ, Wells PB, Reitberg DP, Walczad P, Van Tyle JH: A randomized clinical trial of moxalactam alone versus tobramycin plus clindamycin in abdominal sepsis. Annals of Surgery 1983, 198: 35-41.
10. Nichols RL, Smith JW, Klein DB, Trunkey DD, Cooper RH, Adinolfi MF: Risk of infection after penetrating abdominal trauma. New England Journal of Medicine 1984, 311: 1065-1070.
11. Yellin AE, Heseltine PN, Berne TV, Appleman MD, Gill MA, Riggio CE, Appelman MD, Gill MA, Riggio CE, Chenella FC: The role of Pseudomonas species in patients treated with ampicillin and sulbactam for gangrenous and perforated appendicitis. Surgery, Gynecology and Obstetrics 1985, 161: 303-307.
12. Ho JL, Barza M: Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection. Antimicrobial Agents and Chemotherapy 1987, 31: 485-491.
13. Hofstetter SR, Pacher HL, Bailey AA, Coppa GF: A prospective comparison of two regimens of prophylactic antibiotics in abdominal trauma: cefoxitin vs triple drug. Journal of Trauma 1984, 24: 307-310.
14. Moellering RC: Enterococcal infections in patients treated with moxalactam. Reviews of Infectious Diseases 1982, 4, Supplement: 708-711.
15. Burnett RJ, Haverstook DC, Dellinger EP, Reinhart HH, Bohnen JM, Rostein OD, Vogel SB, Solomkin JS: Definition of the role of enterococcus in intra-abdominal infection: analysis of a prospective randomized trial. Surgery 1995, 118: 716-721.
16. Zervos MJ, Dembry L: Enterococcus in surgical infections: virulence, epidemiology, and resistance. Infectious Disease in Clinical Practice 1994, 3, Supplement 1: 14-20.
17. Finegold SM, and the National Committee for Clinical Laboratory Standards Working Group on Anaerobic Susceptibility Testing: Susceptibility testing of anaerobic bacteria. Journal of Clinical Microbiology 1988, 26: 1253-1256.
18. Bohen JM, Solomkin JS, Dellinger EP, Bjornson HS, Page CP: Guidelines for clinical care: anti-infective agents for intra-abdominal infection. Archives of Surgery 1992, 127: 83-89.
19. Fry DE: Treatment options for early intra-abdominal infection. Infectious Disease in Clinical Practice 1994, 3, Supplement 1: 1-6.
20. Solomkin JS, Meakins JL, Allo MD, Dellinger EP, Simmons RL: Antibiotic trials in intra-abdominal infections. A critical evaluation of study design and outcome reporting. Annals of Surgery 1984, 200: 29-39.
21. Nysrtom PO, Bax R, Dellinger EP, Dominioni L, Knaus WA, Meakins JL, Ohmann C, Salomkin JS, Wacha H, Wittmann DA: Proposed definitions for diagnosis, severity scoring, stratification, and outcome for trials on intra-abdominal infection. World Journal of Surgery 1990, 14: 148-158.
22. Dellinger ER, Wertz MJ, Meakins JL, Solomkin JS, Allo MD, Howard RJ, Simmons RL: Surgical infection stratification system for intra-abdominal infection. Multicenter trial. Archives of Surgery 1985, 120: 21-29.
23. Geckler RW, Eng RH, Fabian TC, Echols RM, Jemsek JG, LeFrock JL, Mogabgab WC, Wilson SE: A multicenter comparative study of cefotetan once daily and cefoxitin thrice daily for the treatment of the skin and superficial soft tissue. American Journal of Surgery 1988, 155, Supplement 5A: 91-95.
24. Wilson SE, Boswick JA, Duma RJ, Echols RM, Jemsek JG, Lerner R, Lewis RT, Najem AZ, Press RA, Rittenbury MS: Cephalosporin therapy in intra-abdominal infections. A multicenter, randomized, comparative study of cefotetan, moxalactam, and cefoxitin. American Journal of Surgery 1988, 155, Supplement 5A: 61-66.
25. Lewis RT, Duma RJ, Echols RM, Jemsek JG, Najem AZ, Press RA, Stone HH, Ton GT, Wilson SE: Comparative study of cefotetan and cefoxitin in the treatment of intra-abdominal infections. American Journal of Obstetrics and Gynecology 1988, 158: 728-735.
26. Walker AP, Nichols RL, Wilson RF, Bivens BA, Trunkey DD, Edmiston CE, Smith JW, Condon RE: Efficacy of a beta-lactamase inhibitor combination for serious intra-abdominal infections. Annals of Surgery 1993, 217: 115-121.
27. Solomkin JS, Hemsell DL, Sweet R, Tally F, Bartlett JG: Evaluation of new anti-infective drugs for the treatment of intra-abdominal infections. Clinical Infectious Diseases 1992, 15, Supplement 1: 33-42.
28. Calandra GB, Norden C, Nelson JD, Mader JT: Evaluation of new anti-infective drugs for the treatment of selected infections of the skin and skin structure. Clinical Infectious Diseases 1992, 15, Supplement 1: 148-154.
29. Snydman DR, Cuchural GJ, McDermott L, Gill M: Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin. A retrospective analysis. Antimicrobial Agents and Chemotherapy 1992, 36: 540-544.